Discover more
Enhancing our support for pharmaceutical, biotech, and medtech companies
By integrating PHE's in-country expertise with Cencora’s robust capabilities, we are now better equipped to address your evolving needs in the dynamic pharmaceutical landscape. This collaboration allows us to offer more comprehensive in-market solutions, including regulatory affairs, pharmacovigilance, exploitant status services, and development consulting.
“This addition is a significant milestone for our market access team, empowering us to better serve our clients and aligns with our strategic vision," noted Tommy Bramley, Senior Vice President of Market Access and Healthcare Consulting. "By combining PHE’s in-country expertise with Cencora’s robust capabilities, we are now better equipped and strategically well-positioned to navigate a dynamic and evolving pharmaceutical landscape, including the upcoming implementation of the Joint Clinical Assessment (JCA) process starting in January 2025. Collectively we strive to accelerate innovations, optimize access, and maximize outcomes for patients.”
Tommy BramleySenior Vice President, Market Access and Healthcare Consulting, Cencora
Discover our market access and healthcare consulting capabilities
Market access strategy
Real-world evidence
HEOR
Regulatory affairs
Pharmacovigilance
Exploitant status services
Clinical services
Connect with our global consulting services experts
We leverage our depth of knowledge and our breadth of offerings around the world to unlock critical insights and deliver business-changing results for our pharma partners.
Our extensive portfolio of solutions includes:
- Statistics and data science
- Science and development support
- Pharmacovigilance
- Regulatory affairs
- Commercialization
- Quality management compliance
- Supply chain and logistics
- Patient support
- Market access
- Field solutions
- Financial services
- Management consulting services
- Mergers and acquisition support